Moderna's mRNA-based flu vaccine shows promise in early-stage study
This data, though limited, puts Moderna ahead of other drugmakers, including rival Pfizer Inc, that are also testing their flu vaccine based on messenger RNA.
Moderna's logo is reflected in a drop on a syringe needle in this illustration taken November 9, 2020.(photo credit: REUTERS)ByREUTERSUpdated:
